Exaggerated neurological side-effects of oral and intravesical oxybutynin in a patient with multiple sclerosis.
Vaidyanathan
S
S
Krishnan
K R
KR
Soni
B M
BM
Fraser
M H
MH
D000328:Adult; D018680:Cholinergic Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008333:Mandelic Acids / Q000008:administration & dosage / Q000009:adverse effects*; D009103:Multiple Sclerosis / Q000150:complications*; D012996:Solutions
D018680:Cholinergic Antagonists; D008333:Mandelic Acids; D012996:Solutions; C005419:oxybutynin